Patents by Inventor Iwao Waga
Iwao Waga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9454642Abstract: The present invention provides a prediction device, a prediction method, a program, and a recording medium, with which whether or not desired aptamer sequences are enriched can be predicted easily. The prediction device of the present invention 10 includes an input unit 11, a calculation unit 12, and a prediction unit 13. The input unit 11 is a unit through which sequence information on a target aptamer sequence group including selected aptamers in a target pool and a reference aptamer sequence group including reference aptamer sequences are inputted. The calculation unit 12 calculates the free energy of the target aptamer sequence group and the free energy of the reference aptamer sequence group. The prediction unit 13 compares the free energy of these sequence groups, and predicts that the target pool is an enriched pool when the free energy of the target aptamer sequence group is lower than the free energy of the reference aptamer sequence group.Type: GrantFiled: July 2, 2011Date of Patent: September 27, 2016Assignees: NEC Solution Innovators, Ltd., KANAGAWA PREFECTURAL HOSPITAL ORGANIZATIONInventors: Jou Akitomi, Shintarou Katou, Shotaro Tsuji, Iwao Waga
-
Publication number: 20160245798Abstract: The present invention provides a detection instrument capable of easily detecting an intended detection object without any skilled technique. The detection instrument (1) of the present invention includes a detection portion (12), a detection reagent which develops a color by specifically reacting with a detection object in a sample is placed in the detection portion (12), positional information of the detection reagent in the detection portion (12) is information on the detection object, and color development of the detection reagent can be optically read. It is preferred that a bar code is formed in the detection portion (12), and the detection reagent is placed as a part of the bar code.Type: ApplicationFiled: May 2, 2016Publication date: August 25, 2016Applicant: NEC SOLUTION INNOVATORS, LTD.Inventor: IWAO WAGA
-
Publication number: 20160230212Abstract: The present invention provides a novel method that can analyze a target easily utilizing binding nucleic acid molecules and an analysis kit for use in the method. The analysis method of the present invention includes: a complex formation step of causing a binding nucleic acid molecule that binds to the target and a sample to come into contact with each other to form a complex of the binding nucleic acid molecule and the target in the sample; a nuclease treatment step of releasing a nucleic acid monomer from at least one of a complex fraction and a non-complex fraction by a nuclease treatment; an enzyme treatment step of reacting the released nucleic acid monomer with an enzyme for which the nucleic acid monomer is a substrate; a detection step of detecting the enzyme reaction; and an analysis step of analyzing the target that has formed the complex from the result of detecting the enzyme reaction.Type: ApplicationFiled: July 23, 2014Publication date: August 11, 2016Applicant: NEC Solution Innovators, Ltd.Inventors: Yoshihito YOSHIDA, Katsunori HORII, Iwao WAGA
-
Publication number: 20160202154Abstract: The present invention is intended to provide a novel sensor for target analysis and a target analysis method using the same. The sensor for target analysis according to the present invention includes a single-stranded nucleic acid molecule. The single-stranded nucleic acid molecule includes a first catalytic nucleic acid region (D1), a second catalytic nucleic acid region (D2), and a binding nucleic acid region (Ap) that binds to a target. The single-stranded nucleic acid molecule includes the first catalytic nucleic acid region (D1) at one end of the binding nucleic acid region (Ap) and the second catalytic nucleic acid region (D2) at the other end of the binding nucleic acid (Ap). In the absence of a target, the catalytic function by the first catalytic nucleic acid region (D1) and the second catalytic nucleic acid region (D2) is inhibited.Type: ApplicationFiled: June 27, 2014Publication date: July 14, 2016Applicant: NEC Solution Innovators, Ltd.Inventors: Katsunori HORII, Jou AKITOMI, Naoto KANEKO, Iwao WAGA
-
Patent number: 9382544Abstract: An aptamer capable of binding to a histidine peptide is provided. A nucleic acid used as the aptamer capable of binding to a histidine peptide may be a nucleic acid containing the base sequence of SEQ ID NO: 17, SEQ ID NO: 18, or containing a base sequence obtained by substitution, deletion, addition, or insertion of one or more bases in SEQ ID NO: 17 or 18.Type: GrantFiled: May 14, 2010Date of Patent: July 5, 2016Assignee: NEC Solution Innovators, Ltd.Inventors: Shotaro Tsuji, Jou Akitomi, Shintarou Katou, Iwao Waga, Takashi Ohtsu
-
Publication number: 20160169875Abstract: The present invention is to provide a new sensor for melamine detection. The nucleic acid sensor for melamine analysis of the present invention includes a polynucleotide (x1) that includes a catalytic nucleic acid molecule (D) that activates a catalytic function and a binding nucleic acid molecule (A) that binds to melamine. The polynucleotide (x1) has any one of the base sequences of SEQ ID NOs: 1 to 14, and n and m are positive integers. In the nucleic acid sensor, since the catalytic function of the catalytic nucleic acid molecule (D) is inhibited in the absence of melamine and the catalytic function of the catalytic nucleic acid molecule (D) is activated in the presence of melamine, melamine can be analyzed by detecting the catalytic function.Type: ApplicationFiled: July 23, 2013Publication date: June 16, 2016Inventors: Katsunori Horii, Naoto Kaneko, Jou Akitomi, Shintarou Katou, Makio Furuichi, Iwao Waga
-
Publication number: 20160148117Abstract: The present invention provides an attribute estimation system capable of acquiring an image of a person whose attributes are to be estimated accurately and informing the person of an attribute estimation result. The attribute estimation system (1) includes: a mirror (11) equipped with an information display terminal (12); and an attribute estimation device (3). The information display terminal (12) includes an image acquisition unit. The information display terminal (12) is disposed on the mirror (11) in such a manner that the information display terminal (12) can display information on a surface of the mirror (11) and that the image acquisition unit can acquire an image of a user of the mirror (11). The information display terminal (12) and the attribute estimation device (3) can be connected to each other via a communication line network (2). The attribute estimation device (3) generates attribute information estimated from the acquired image of the user of the mirror (11).Type: ApplicationFiled: May 19, 2014Publication date: May 26, 2016Inventors: IWAO WAGA, TOMOMI KINOSHITA, MITSUHIRO FUJITA
-
Publication number: 20160146772Abstract: The present invention is intended to provide a novel fluorescence sensor for target analysis, a kit for target analysis, and a target analysis method using the same. The fluorescence sensor for target analysis according to the present invention includes a nucleic acid molecule that includes a G-quartet-forming nucleic acid region (D) that forms a G-quartet and a binding nucleic acid region (A) that binds to a target. In the absence of a target, formation of a G-quartet in the G-quartet-forming nucleic acid region (D) is inhibited. In the presence of a target, the target comes into contact with the binding nucleic acid region (A), the G-quartet is formed in the G-quartet-forming nucleic acid region (D) due to the contact, the G-quartet-forming region (D) and porphyrin forms a complex, and the complex generates fluorescence.Type: ApplicationFiled: June 27, 2014Publication date: May 26, 2016Applicant: NEC Solution Innovators, Ltd.Inventors: Naoto KANEKO, Ikuo SHIRATORI, Katsunori HORII, Jou AKITOMI, Iwao WAGA
-
Patent number: 9278108Abstract: A nucleic acid molecule that can bind to HMGB1 protein and applications thereof are provided. A nucleic acid molecule having a dissociation constant for HMGB1 protein of 5×10?7 or less can be used as the nucleic acid molecule that can bind to HMGB1 protein. The HMGB1 binding nucleic acid molecule can bind to HMGB1 protein that is known to be a cause of diseases such as cancer and inflammation, and it is therefore possible to obtain an effect to prevent and an effect to treat such diseases by allowing the HMGB1 binding nucleic acid molecule to bind to HMGB1 protein in a living body.Type: GrantFiled: July 16, 2010Date of Patent: March 8, 2016Assignees: NEC Solution Innovators, Ltd., Kanagawa Prefectural Hospital OrganizationInventors: Hiromi Takenaka, Jou Akitomi, Shintarou Katou, Shotaro Tsuji, Takashi Ohtsu, Iwao Waga
-
Publication number: 20160060630Abstract: The present invention provides a novel technique by which the redox activity of a nucleic acid molecule can be evaluated. An evaluation method of the present invention includes: a detection step of electrochemically detecting a redox reaction to a substrate, the redox reaction being catalyzed by a nucleic acid molecule to be evaluated, using a device that electrochemically detects a redox reaction; and an evaluation step of evaluating redox activity of the nucleic acid molecule from a result of the detection of the redox reaction. As the device, a device in which a base provided with a detection portion is included, the detection portion includes an electrode system, and the nucleic acid molecule to be evaluated is arranged on the base is used. In the present invention, it is preferred that a plurality of kinds of nucleic acid molecule to be evaluated is arranged on the base, and the plurality of kinds of nucleic acid molecules to be evaluated is evaluated by a single device.Type: ApplicationFiled: November 16, 2015Publication date: March 3, 2016Inventors: Naoto KANEKO, Katsunori Horii, Jou Akitomi, Shintarou Katou, Iwao Waga
-
Publication number: 20150167106Abstract: The present invention provides a nucleic acid molecule applicable to detection of influenza virus. The nucleic acid molecule according to the present invention is a nucleic acid molecule that binds to an influenza virus, including at least one polynucleotide selected from the group consisting of the following polynucleotides (a) to (d): (a) a polynucleotide that has any of base sequences of SEQ ID NOs: 1 to 30; (b) a polynucleotide that has a base sequence obtained by deletion, substitution, insertion, and/or addition of one or more bases in any of the base sequences of the polynucleotide (a) and binds to the influenza virus; (c) a polynucleotide that has a base sequence with an identity of at least 80% to any of the base sequences of the polynucleotide (a) and binds to the influenza virus; and (d) a polynucleotide that has a base sequence complementary to a polynucleotide hybridizing to any of the base sequences of the polynucleotide (a) under stringent conditions and binds to the influenza virus.Type: ApplicationFiled: April 25, 2013Publication date: June 18, 2015Applicant: NEC Solution Innovators, Ltd.Inventors: Ikuo Shiratori, Jou Akitomi, Katsunori Horii, Makio Furuichi, Iwao Waga
-
Publication number: 20150086980Abstract: The present invention provides a novel sensor for detecting streptavidin (SA). The nucleic acid sensor for analyzing SA of the present invention includes the following nucleic acid element that includes a catalyst nucleic acid molecule (D) that exerts a catalytic function and a binding nucleic acid molecule (A) that binds to SA. The nucleic acid element is a double-stranded nucleic acid element including a first strand and a second strand. The first strand (ss1) includes the binding nucleic acid molecule (A), a loop-forming sequence (L1), and the catalyst nucleic acid molecule (D) linked in this order. The second strand (ss2) includes a stem-forming sequence (SA), a loop-forming sequence (L2), and a stem-forming sequence (SD) linked in this order.Type: ApplicationFiled: March 21, 2013Publication date: March 26, 2015Applicant: NEC Solution Innovators, Ltd.Inventors: Katsunori Horii, Naoto Kaneko, Jou Akitomi, Shintaro Kato, Iwao Waga
-
Publication number: 20150056720Abstract: The present invention provides a novel sensor for detecting a target. The nucleic acid sensor of the present invention includes a nucleic acid element that includes a catalyst nucleic acid molecule (D) that exerts a catalytic function and a binding nucleic acid molecule (A) that binds to a target. The nucleic acid element is a double-stranded nucleic acid element including a first strand and a second strand. The first strand (ss1) includes the binding nucleic acid molecule (A), a loop-forming sequence (L1), and the catalyst nucleic acid molecule (D) linked in this order. The second strand (ss2) includes a stem-forming sequence (SA), a loop-forming sequence (L2), and a stem-forming sequence (SD) linked in this order.Type: ApplicationFiled: December 12, 2012Publication date: February 26, 2015Applicant: NEC Solution Innovators, Ltd.Inventors: Katsunori Horii, Naoto Kaneko, Jou Akitomi, Shintarou Katou, Iwao Waga
-
Publication number: 20140370618Abstract: The present invention is to provide a nucleic acid molecule having a binding affinity to a rodent-derived IgG antibody, which can be prepared easier than an antibody and has a binding affinity equivalent or superior to that of an antibody, a binder using the nucleic acid molecule, a detection reagent, and a detection kit. The nucleic acid molecule of the present invention has a binding affinity to a rodent-derived IgG antibody and has a dissociation constant of 1 ?M or less. The binder for a rodent-derived IgG antibody of the present invention includes the nucleic acid molecule of the present invention. The detection reagent for detecting a rodent-derived IgG antibody of the present invention includes the binder for a rodent-derived IgG antibody of the present invention. The detection kit for detecting a rodent-derived IgG antibody of the present invention includes the detection reagent for detecting a rodent-derived IgG antibody of the present invention.Type: ApplicationFiled: July 21, 2014Publication date: December 18, 2014Applicant: NEC SOFT, LTD.Inventors: Hiromi TAKENAKA, Yoshihito YOSHIDA, Katsunori HORII, Makio FURUICHI, Hirotaka YAGI, Jou AKITOMI, Mineko YAMAGUCHI, Shintarou KATOU, Kensaku NISHIKATA, Iwao WAGA
-
Patent number: 8852954Abstract: The invention provides a nucleic acid molecule having a binding affinity to a rodent-derived IgG antibody, which can be prepared easier than an antibody and has a binding affinity equivalent or superior to that of an antibody, a binder using the nucleic acid molecule, a detection reagent, and a detection kit. The nucleic acid molecule of the invention has a binding affinity to a rodent-derived IgG antibody and has a dissociation constant of 1 ?M or less. The binder for a rodent-derived IgG antibody of the present invention includes the nucleic acid molecule of the present invention. The detection reagent for detecting a rodent-derived IgG antibody of the invention includes the binder for a rodent-derived IgG antibody of the invention. The detection kit for detecting a rodent-derived IgG antibody of the invention includes the detection reagent for detecting a rodent-derived IgG antibody of the invention.Type: GrantFiled: August 21, 2009Date of Patent: October 7, 2014Assignee: NEC Solution Innovators, Ltd.Inventors: Hiromi Takenaka, Yoshihito Yoshida, Katsunori Horii, Makio Furuichi, Hirotaka Yagi, Jou Akitomi, Mineko Yamaguchi, Shintarou Katou, Kensaku Nishikata, Iwao Waga
-
Patent number: 8822667Abstract: The present invention provides a nucleic acid molecule capable of binding to c-Met as a substance that can be used for clarification of the pathogenic mechanism of diseases caused by c-Met, diagnosis and treatment of the diseases, and the like, and also the use thereof. The c-Met binding nucleic acid molecule of the present invention is any one of the following nucleic acid molecules (A1), (A2), (B1), and (B2).Type: GrantFiled: July 26, 2011Date of Patent: September 2, 2014Assignees: NEC Solution Innovators, Ltd., Kanagawa Prefectural Hospital OrganizationInventors: Naomi Hirabayashi, Shotaro Tsuji, Jou Akitomi, Shintarou Katou, Iwao Waga, Takashi Ohtsu
-
Publication number: 20140128589Abstract: The present invention provides a novel technique by which the redox activity of a nucleic acid molecule can be evaluated. An evaluation method of the present invention includes: a detection step of electrochemically detecting a redox reaction to a substrate, the redox reaction being catalyzed by a nucleic acid molecule to be evaluated, using a device that electrochemically detects a redox reaction; and an evaluation step of evaluating redox activity of the nucleic acid molecule from a result of the detection of the redox reaction. As the device, a device in which a base provided with a detection portion is included, the detection portion. includes an electrode system, and the nucleic acid molecule to be evaluated is arranged on the base is used. In the present invention, it is preferred that a plurality of kinds of nucleic acid molecule to be evaluated is arranged on the base, and the plurality of kinds of nucleic acid molecules to be evaluated is evaluated by a single device.Type: ApplicationFiled: July 2, 2012Publication date: May 8, 2014Inventors: Naoto Kaneko, Katsunori Horii, Jou Akitomi, Shintarou Katou, Iwao Waga
-
Publication number: 20130273530Abstract: The present invention provides a technique capable of simply analyzing a target to be analyzed. An analytical device of the present invention includes a basal plate; a nucleic acid element; and a detection section of detecting a signal. The nucleic acid element and the detection section are arranged on the basal plate. The nucleic acid element includes a first nucleic acid molecule and a second nucleic acid molecule. The first nucleic acid molecule is a nucleic acid molecule capable of binding to a target. The second nucleic acid molecule is a nucleic acid molecule capable of binding to streptavidin. When the target does not bind to the first nucleic acid molecule, a binding capacity of the second nucleic acid molecule to the streptavidin is inactivated. When the target binds to the first nucleic acid molecule, a binding capacity of the second nucleic acid molecule to the streptavidin is activated. The detection section detects binding between the second nucleic acid molecule and the streptavidin.Type: ApplicationFiled: December 22, 2011Publication date: October 17, 2013Applicant: NEC SOFT, LTD.Inventors: Katsunori Horii, Shintarou Katou, Jou Akitomi, Iwao Waga
-
Publication number: 20130273645Abstract: The present invention provides a detection instrument capable of easily detecting an intended detection object without any skilled technique. The detection instrument (1) of the present invention includes a detection portion (12), a detection reagent which develops a color by specifically reacting with a detection object in a sample is placed in the detection portion (12), positional information of the detection reagent in the detection portion (12) is information on the detection object, and color development of the detection reagent can be optically read. It is preferred that a bar code is formed in the detection portion (12), and the detection reagent is placed as a part of the bar code.Type: ApplicationFiled: December 19, 2011Publication date: October 17, 2013Applicant: NEC SOFT, LTD.Inventor: Iwao Waga
-
Publication number: 20130123350Abstract: The present invention provides a nucleic acid molecule capable of binding to c-Met as a substance that can be used for clarification of the pathogenic mechanism of diseases caused by c-Met, diagnosis and treatment of the diseases, and the like, and also the use thereof. The c-Met binding nucleic acid molecule of the present invention is any one of the following nucleic acid molecules (A1), (A2), (B1), and (B2).Type: ApplicationFiled: July 26, 2011Publication date: May 16, 2013Applicants: KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION, NEC SOFT, LTD.Inventors: Naomi Hirabayashi, Shotaro Tsuji, Jou Akitomi, Shintarou Katou, Iwao Waga, Takashi Ohtsu